A.P. Pharma Announces Chief Executive Officer Succession Plan.REDWOOD CITY Redwood City, city (1990 pop. 66,072), seat of San Mateo co., W Calif., on San Francisco Bay; inc. 1868. Manufactures include commmunications, electrical, electronic, and medical equipment. , Calif. -- A.P. Pharma, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :APPA), a specialty pharmaceuticals company, today announced that its board of directors has initiated an executive succession program designed to recruit a well-qualified successor for Gregory Turnbull, the Company's current President and Chief Executive Officer. Mr. Turnbull, a long-time director of the Company, assumed the CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. position in October 2006 when Michael O'Connell, the incumbent at that time, departed on medical leave. Mr. Turnbull plans to continue to serve as A.P. Pharma's CEO until his successor is successfully engaged, at which time he will remain on the board and also continue to be a member of its recently formed executive committee. The A.P. Pharma board has retained the services of Levin lev·in n. Archaic Lightning. [Middle English levene, levin; see leuk- in Indo-European roots.] & Company, an executive search firm specializing in the life sciences field, to assist in the CEO recruitment. Christos Richards Rich·ards , Dickinson Woodruff 1895-1973. American physician. He shared a 1956 Nobel Prize for developing cardiac catheterization. , President of Levin & Company, is leading the engagement. About A.P. Pharma A.P. Pharma is a specialty pharmaceutical company focused on the development of ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The Company's primary focus is the development and commercialization of its bioerodible injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. and implantable systems under the trade name Biochronomer[TM]. Initial target areas of application for the Company's drug delivery technology include anti-nausea, pain management, anti-inflammation and DNA/RNAI applications. For further information visit the Company's web site at www.appharma.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion